Total Payments
$137,157
2024 Payments
$64,986
Companies
7
Transactions
163
Medicare Patients
2,855
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$93,980 (68.5%)
Travel$22,986 (16.8%)
Food & Beverage$20,190 (14.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $93,980 | 43 | 68.5% |
| Travel and Lodging | $22,986 | 58 | 16.8% |
| Food and Beverage | $20,190 | 62 | 14.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $136,669 | 135 | $0 (2024) |
| GlaxoSmithKline, LLC. | $246.42 | 14 | $0 (2023) |
| SANOFI PASTEUR INC. | $116.40 | 6 | $0 (2024) |
| PFIZER INC. | $51.17 | 3 | $0 (2023) |
| ALK-Abello, Inc | $42.21 | 3 | $0 (2019) |
| Greer Laboratories, Inc. | $16.41 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $15.11 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64,986 | 50 | GENZYME CORPORATION ($64,946) |
| 2023 | $28,975 | 42 | GENZYME CORPORATION ($28,938) |
| 2022 | $18,295 | 20 | GENZYME CORPORATION ($18,274) |
| 2021 | $1,975 | 6 | GENZYME CORPORATION ($1,898) |
| 2020 | $2,241 | 9 | GENZYME CORPORATION ($2,152) |
| 2019 | $2,746 | 8 | GENZYME CORPORATION ($2,686) |
| 2018 | $17,863 | 23 | GENZYME CORPORATION ($17,775) |
| 2017 | $76.34 | 5 | ALK-Abello, Inc ($25.29) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), MENQUADFI, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Vaccines | ||||||
| 09/24/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,990.00 | General |
| Category: Genetic Disease | ||||||
| 09/24/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,990.00 | General |
| Category: Genetic Disease | ||||||
| 09/23/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,174.00 | General |
| Category: Genetic Disease | ||||||
| 09/23/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Travel and Lodging | In-kind items and services | $1,168.12 | General |
| Category: Genetic Disease | ||||||
| 09/23/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Travel and Lodging | In-kind items and services | $930.59 | General |
| Category: Genetic Disease | ||||||
| 09/23/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Travel and Lodging | Cash or cash equivalent | $325.52 | General |
| Category: Genetic Disease | ||||||
| 09/23/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Travel and Lodging | Cash or cash equivalent | $136.09 | General |
| Category: Genetic Disease | ||||||
| 09/23/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Food and Beverage | Cash or cash equivalent | $32.95 | General |
| Category: Genetic Disease | ||||||
| 09/11/2024 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), MENQUADFI, BEYFORTUS | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Vaccines | ||||||
| 07/30/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,990.00 | General |
| Category: Genetic Disease | ||||||
| 07/30/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,791.00 | General |
| Category: Genetic Disease | ||||||
| 07/30/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Food and Beverage | In-kind items and services | $82.88 | General |
| Category: Genetic Disease | ||||||
| 07/29/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,990.00 | General |
| Category: Genetic Disease | ||||||
| 07/29/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Travel and Lodging | Cash or cash equivalent | $617.13 | General |
| Category: Genetic Disease | ||||||
| 07/29/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Food and Beverage | Cash or cash equivalent | $308.33 | General |
| Category: Genetic Disease | ||||||
| 07/29/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| Category: Genetic Disease | ||||||
| 07/28/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,975.00 | General |
| Category: Genetic Disease | ||||||
| 07/28/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Travel and Lodging | In-kind items and services | $1,089.77 | General |
| Category: Genetic Disease | ||||||
| 07/28/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Travel and Lodging | In-kind items and services | $664.03 | General |
| Category: Genetic Disease | ||||||
| 07/17/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,174.00 | General |
| Category: Genetic Disease | ||||||
| 07/17/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Travel and Lodging | In-kind items and services | $690.05 | General |
| Category: Genetic Disease | ||||||
| 07/17/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Travel and Lodging | In-kind items and services | $249.33 | General |
| Category: Genetic Disease | ||||||
| 07/17/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Travel and Lodging | In-kind items and services | $248.79 | General |
| Category: Genetic Disease | ||||||
| 07/17/2024 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Travel and Lodging | Cash or cash equivalent | $244.99 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 559 | 10,514 | $1.4M | $444,894 |
| 2021 | 3 | 2,296 | 24,454 | $4.2M | $987,828 |
Total Patients
2,855
Total Services
34,968
Medicare Billing
$1.4M
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 291 | 5,481 | $864,754 | $238,226 | 27.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 268 | 5,033 | $503,300 | $206,668 | 41.1% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 988 | 11,444 | $2.1M | $495,385 | 23.2% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 895 | 11,079 | $1.1M | $458,449 | 41.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 413 | 1,931 | $995,900 | $33,994 | 3.4% |
About Dr. Stuart Ditchek, M.D
Dr. Stuart Ditchek, M.D is a General Practice healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528068103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Ditchek, M.D has received a total of $137,157 in payments from pharmaceutical and medical device companies, with $64,986 received in 2024. These payments were reported across 163 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($93,980).
As a Medicare-enrolled provider, Ditchek has provided services to 2,855 Medicare beneficiaries, totaling 34,968 services with total Medicare billing of $1.4M. Data is available for 2 years (2021–2022), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Brooklyn, NY
- Active Since 07/26/2005
- Last Updated 05/16/2018
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528068103
Products in Payments
- CERDELGA (Drug) $48,099
- CEREZYME (Biological) $44,033
- NO PRODUCT DISCUSSED (Drug) $17,775
- BEXSERO (Biological) $246.42
- CEREZYME (Drug) $124.98
- MENACTRA (Drug) $41.21
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $24.70
- PREVNAR 13 (Biological) $21.54
- VAXELIS (Biological) $20.49
- Odactra (Drug) $16.92
- TRUMENBA (Biological) $16.43
- Oralair (Drug) $16.41
- BEYFORTUS (Biological) $15.55
- SYNAGIS (Biological) $15.11
- PENTACEL (Drug) $14.45
- Ragwitek (Biological) $13.29
- PREVNAR - 13 (Biological) $13.20
- Grastek (Biological) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Brooklyn
Dr. Anthony Ramirez, Dds, DDS
General Practice — Payments: $124,499
General Practice $124,499
Dr. Isaac Tawil, D.d.s, D.D.S
General Practice — Payments: $118,913
General Practice $118,913
Jerome Cantor
General Practice — Payments: $32,014
General Practice $32,014
Dr. Bruce Lish, Dds, DDS
General Practice — Payments: $18,516
General Practice $18,516
Dr. Margarita Degtyareva, Dds, DDS
General Practice — Payments: $13,683
General Practice $13,683
Dr. Lyudmila Spektor, D.d.s, D.D.S
General Practice — Payments: $12,237
General Practice $12,237